胰岛素(Insulet),一个胰岛素泵制造商,报告Q1收入远远超过预测,库存猛增20%。 Insulet, an insulin pump maker, reported Q1 earnings well above forecasts, with stock jumping 20%.

生产胰岛素泵的Insulet Corporation,报告2025年Q1收入强劲,调整后收入为每股1.02美元,超过预测。 Insulet Corporation, which makes insulin pumps, reported strong Q1 2025 earnings, with adjusted earnings of $1.02 per share, exceeding forecasts. 销售额增长了29%,达到5.69亿美元,其全nipod收入的增长对此起到了促进作用。 Sales rose 29% to $569 million, fueled by the growth of its Omnipod revenue. 该公司的股票猛涨了20%,并将全年收入增长预测提高至19-22%。 The company's stock surged 20%, and it raised its full-year revenue growth forecast to 19-22%. Insulet的CEO强调了该公司在糖尿病管理技术方面的进展。 Insulet's CEO highlighted the company's progress in diabetes management technology.